Lung

Lung
2025-02-21T00:00:00.000+11:00
Ongoing

BO45217

BO45217
Non-small cell lung cancer (NSCLC)

A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of Divarasib versus Sotorasib or Adagrasib in patients with previously treated KRAS G12C-Positive advanced or metastatic non-small cell Lung Cancer.

A phase III, randomized, open-label, multicenter study evaluating the efficacy and safety of Divarasib versus Sotorasib or Adagrasib in patients with previously treated KRAS G12C-Positive advanced or metastatic non-small cell Lung Cancer.

Trial overview

Clinical Area

Medical Oncology

Disease

Non-small cell lung cancer (NSCLC)

Disease site

Lung & bronchus

Study Phase

III

Trial Identifiers

Registration number: NCT06497556

https://clinicaltrials.gov/

GenesisCare Location(s)
North Shore
location pin icon

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

phone icon (02) 8037 4100 email icon admin.northshore@genesiscare.com
NSW
North Shore
Principal Investigator(s)

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.